Phase 2 study of nivolumab for patients with meningiomas refractory to surgery and radiotherapy with immune-related response criteria.

Authors: Hikaru Sasaki, Tetsuya Takimoto, Ryo Takemura, Kohei Nakamura, Ryutaro Kawano, Shigeru Yamaguchi, Kazuhide Adachi, Masayuki Kanamori, Daisuke Kuga, Dai Kamamoto, Masato Nakaya, Utaro Hino, Hirokazu Fujiwara, Tomoru Miwa, Hiroshi Nishihara, Hideyuki Saya, Yutaka Kawakami

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.2084

Source: Full article

---

Abstract

2084